Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment (2009)
- Authors:
- USP affiliated authors: VALERA, FABIANA CARDOSO PEREIRA - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP ; LIMA, WILMA TEREZINHA ANSELMO - FMRP
- Unidade: FMRP
- DOI: 10.1111/j.1365-2222.2008.03144.x
- Subjects: PÓLIPOS NASAIS; CITOCINAS; FÁRMACOS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Clinical and Experimental Allergy
- ISSN: 1365-2222
- Volume/Número/Paginação/Ano: v. 39, p. 81-88, 2009
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
VALERA, Fabiana Cardoso Pereira et al. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment. Clinical and Experimental Allergy, v. 39, p. 81-88, 2009Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2222.2008.03144.x. Acesso em: 23 abr. 2024. -
APA
Valera, F. C. P., Queiroz, R., Scrideli, C. A., Tone, L. G., & Anselmo-Lima, W. T. (2009). Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment. Clinical and Experimental Allergy, 39, 81-88. doi:10.1111/j.1365-2222.2008.03144.x -
NLM
Valera FCP, Queiroz R, Scrideli CA, Tone LG, Anselmo-Lima WT. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment [Internet]. Clinical and Experimental Allergy. 2009 ; 39 81-88.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1111/j.1365-2222.2008.03144.x -
Vancouver
Valera FCP, Queiroz R, Scrideli CA, Tone LG, Anselmo-Lima WT. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment [Internet]. Clinical and Experimental Allergy. 2009 ; 39 81-88.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1111/j.1365-2222.2008.03144.x - Effect of DHMEQ, a NF-kappaB inhibitor, on nasal fibroblasts polyps cultures
- Antitumor effect of the dehydroxymethylepoxyquinomicin (DHMEQ), a novel nuclear factor-B inhibitor, in pediatric osteosarcoma cell lines
- Effect of DHMEQ, a NF-kAPPAB inhibitor, on nasal cultures
- DHMEQ effect of ICAM-1, VCAM-1 and rantes expression in nasal polyps
- Expression of transcription factors NF-'capa'B and AP-1 in nasal polyposis
- Effect of DHMEQ, a NF-KAPPAB inhibitor, on nasal fibroblasts polyps cultures
- Suppression of inflammatory cytokine secretion by an NF-ĸB inhibitor DHMEQ in nasal polyps fibroblasts
- The influence of GRa, GRb, NF-kB and AP-1 expression on nasal polyposis prognosis
- DHMEQ effect of nasal polyps fibroblasts: in vitro preliminary results
- NF-kb expression predicts clinical outcome for nasal polyposis
Informações sobre o DOI: 10.1111/j.1365-2222.2008.03144.x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
